BHV-7000, A Novel, Selective Kv7.2/7.3 Potassium Channel Activator, Demonstrates Dose-Dependent Pharmacodynamic Effects on EEG Parameters in Healthy Adults by Jason Lerner, M.D., Bharat Awsare, M.D., Heather Sevinsky, M.S., Eric Ashbrenner, M.S., Randall Killingsworth, B.A., Racheal Kendrick, PharmD, Emiel Vereycken, M.S., Nigel Colenbier, Ph.D., Caroline Neuray, M.D., Pieter van Mierlo, Ph.D., Jeremy Slater, M.D., David Wyatt, M.D., Irfan Qureshi, M.D., Steven Dworetzky, Ph.D., Michael Bozik, M.D.

Get full text